January 12, 2022
Via: The Wall Street JournalBiopharmaceutical firm Pardes Biosciences Inc. plans to spend a large chunk of the funds it raised through a public offering late last month on a pill it is developing to treat Covid-19, including on manufacturing and hiring more clinical staff. […]
May 2, 2024
April 23, 2024
April 11, 2024
April 23, 2024
April 22, 2024
April 23, 2024
April 26, 2024